ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
OncoC4, Inc.
Genmab
University of Chicago
Exscientia AI Limited
Seagen Inc.
Mayo Clinic
SystImmune Inc.
Guardant Health, Inc.
Numab Therapeutics AG
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Celldex Therapeutics
M.D. Anderson Cancer Center
Numab Therapeutics AG
Tempus AI
University of Pennsylvania
Pfizer
Mayo Clinic
Taproot Health
23andMe, Inc.
Mundipharma Research Limited
Hoffmann-La Roche
ADC Therapeutics S.A.
Celldex Therapeutics
Gilead Sciences
pharmaand GmbH
Canadian Cancer Trials Group
Celldex Therapeutics
Eastern Cooperative Oncology Group
Xencor, Inc.
Xencor, Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
AstraZeneca
Abramson Cancer Center at Penn Medicine
Celgene
Bay Area Gynecology Oncology
Critical Outcome Technologies Inc.
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Sanofi
Santa Maria Biotherapeutics
GOG Foundation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc